Explore evidence

77 %Among all 15 to 45-year-old HIV-infected women, year-3 population-level viral suppression was 77% in intervention communities.

KenyaVIH/sidaobserved year 3published 2020AIDS (London, England)PubMeddocument of 8 observations

3.19 odds_ratioIn a cohort of 309 adolescent girls and young women aged 15–24 years living with HIV in Kisumu County, western Kenya, moderate or severe depression was associated with significantly higher odds of poor antiretroviral therapy adherence (Odds Ratio = 3.19).

KenyaVIH/sidaobserved January to June 2022published 2023International journal of environmental research and public healthPubMeddocument of 4 observations

92 %In Nairobi, knowledge of HIV status was 92% among DREAMS beneficiaries and 69% among non-beneficiaries among adolescent girls and young women aged 15–22 years in 2017.

KenyaVIH/sidaobserved 2017published 2022Journal of epidemiology and community healthPubMeddocument of 6 observations

1,266 womenAmong 1266 pregnant and postpartum women in Western Kenya, there were 35 incident HIV infections.

KenyaVIH/sidapublished 2024PloS onePubMeddocument of 6 observations

0.74 odds_ratioAt visits where women reported being sexually active, having >1 sex partner in the past week was associated with lower likelihood of detecting sperm in genital secretions (OR: 0.74, 96.7% CI: 0.56, 0.98).

KenyaVIH/sidapublished 2011Sexually transmitted diseaseseurope_pmcdocument of 3 observationsDOI 10.1097/olq.0b013e31820369f6

95.5 %In the Standard APS arm, 95.5% (1422/1489) of eligible partners were tested for HIV.

KenyaVIH/sidaobserved 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations

40.8 %At 24 months after antiretroviral therapy initiation, 40.8% (95% CI 40.1–41.6) of pregnant women living with HIV were not retained in care.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 12 observations

9 participantsOf 14 participants who answered the question about preferred type of HIV self-test, nine preferred blood-based HIVST and five preferred oral HIVST.

KenyaVIH/sidapublished 2022Frontiers in public healthPubMeddocument of 5 observations

After six months of antiretroviral therapy follow-up, there was a significant drop in viral load for both HIV mono-infected and HIV/HBV co-infected groups at p<0.001.

Kenyahépatite B · VIH/sidapublished 2021Pan African Medical JournalOpenAlexdocument of 10 observations

42 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 42% of HIV-positive persons had viral suppression at baseline according to fully adjusted estimates.

KenyaVIH/sidaobserved 2013-2017published 2020Epidemiology (Cambridge, Mass.)PubMeddocument of 8 observations

7,283 self-testsParticipants received 7283 HIV self-tests over six months.

KenyaVIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 15 observations

78.7 %In scenario 1, time spent at a facility awaiting sample batching and transport accounted for 78.7% of total turnaround time for HIV viral load monitoring.

KenyaVIH/sidapublished 2024Health policy and planningPubMeddocument of 15 observations

4.1 %Of the 23,673 adults who reported having ever tested for HIV, 937 (4.1%) had ever self-tested for HIV.

KenyaVIH/sidaobserved 2018published 2022BMC public healthPubMeddocument of 3 observations

0.85 relative_riskYounger age at HIV-care enrollment was an individual cofactor of tuberculosis preventive therapy initiation with a relative risk of 0.85 (95% confidence interval: 0.80 to 0.90).

KenyaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

18.8 %Among HIV-positive patients with cancer, non-Hodgkin lymphoma accounted for 18.8% (6 of 32) of malignancies.

Kenyanon-Hodgkin lymphoma · VIH/sidapublished 2023JCO global oncologyPubMeddocument of 8 observations

14.5 daysThe median time to HIV testing among sexual contacts of HIV-positive index clients in Siaya County, Kenya was 14.5 days.

KenyaVIH/sidaobserved June 2017-August 2018published 2020PloS onePubMeddocument of 8 observations

12.7 %In Teso, Western Kenya, HIV-1 subtype D accounted for 8 out of 63 sequenced samples (12.7%).

KenyaVIH/sidaobserved 2019published 2021The Pan African medical journalPubMeddocument of 7 observations

63.9 %The prevalence of unmet contraceptive need among HIV-positive female sex workers in Mombasa, Kenya was 63.9% (95% CI 58.8–68.9%).

KenyaVIH/sidapublished 2019PloS oneeurope_pmcdocument of 4 observationsDOI 10.1371/journal.pone.0218291

1,227 initiationsControlled interrupted time series analysis of PrEP initiations (n = 1227) revealed no significant difference between intervention and control clinics in terms of trends in PrEP initiation.

KenyaVIH/sidaobserved January-December 2019 to January-November 2020published 2021Journal of the International AIDS SocietyPubMeddocument of 8 observations

2,696 follow-up visitsControlled interrupted time series analysis of follow-up visits (n = 2696) revealed no significant difference between intervention and control clinics in terms of trends in on-time returns.

KenyaVIH/sidaobserved January-December 2019 to January-November 2020published 2021Journal of the International AIDS SocietyPubMeddocument of 8 observations

6,234 individualsAmong 6234 children and young adolescents living with HIV (CALWH) who received care in Academic Model Providing Access to Healthcare HIV clinics in Western Kenya between January 2002 and November 2022, the cases comprised those reported dead by November 2022.

KenyaVIH/sidaobserved January 2002 to November 2022published 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

1.42 IRRThe adjusted incidence rate ratio (IRR) for HIV acquisition among men who spent some nights away in the past month at baseline was 1.42 (95% CI 1.11–1.81).

KenyaVIH/sidapublished 2025AIDS and behavioreurope_pmcdocument of 18 observations

2.2 aORDepressive symptomatology was associated with increased odds of viral non-suppression (adjusted odds ratio 2.2; 95% confidence interval 1.2–4.0).

Kenyadépression · VIH/sidapublished 2023AIDS and behaviorPubMeddocument of 3 observations

29.37 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 29,37 % en 2016.

KenyaVIH/sidaobserved 2016HAL · Unilimdocument of 747 observations

11.1 %Among 794 women with 12,437 scheduled visits in the Mobile WAChX trial, a median of 11.1% of visits per woman were late.

KenyaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations